CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
This Quarter Return
-6.4%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$88M
AUM Growth
+$88M
(-18%)
Cap. Flow
-$6.15M
Cap. Flow
% of AUM
-6.99%
Top 10 Holdings %
Top 10 Hldgs %
91.84%
Holding
33
New
7
Increased
14
Reduced
5
Closed
2
Top Buys
| 1 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$1.72M |
| 2 |
Alerian MLP ETF
AMLP
|
$471K |
| 3 |
ABDC
Alcentra Capital Corp
ABDC
|
$325K |
| 4 |
Visa
V
|
$238K |
| 5 |
Mastercard
MA
|
$236K |
Top Sells
| 1 |
Investcorp Credit Management BDC
ICMB
|
$6.32M |
| 2 |
MEI Pharma
MEIP
|
$3.39M |
| 3 |
ARQL
Arqule Inc
ARQL
|
$700K |
| 4 |
Marker Therapeutics
MRKR
|
$146K |
| 5 |
GARS
Garrison Capital Inc.
GARS
|
$13.8K |
Sector Composition
| 1 | Healthcare | 66.39% |
| 2 | Financials | 3.8% |
| 3 | Consumer Discretionary | 0.56% |
| 4 | Industrials | 0.52% |
| 5 | Technology | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBBP
1
DELISTED
Strongbridge Biopharma plc.
SBBP
| $20.7M | 23.51% | 6,612,065 | – | – |
|
|
MTEM
2
DELISTED
Molecular Templates, Inc.
MTEM
| $13.6M | 15.4% | 1,624,241 | – | – |
|
3
KALA BIO
KALA
$78.8M
| $9.6M | 10.9% | 1,504,272 +3,000 | +0.2% | +$19.1K |
|
|
GARS
4
DELISTED
Garrison Capital Inc.
GARS
| $8.44M | 9.58% | 1,223,096 -2,000 | -0.2% | -$13.8K |
|
|
ABDC
5
DELISTED
Alcentra Capital Corp
ABDC
| $7.03M | 7.98% | 838,840 +38,840 | +5% | +$325K |
|
6
SCYNEXIS
SCYX
$34.9M
| $5.67M | 6.44% | 4,325,000 | – | – |
|
|
7
MEI Pharma
MEIP
$160M
| $5.25M | 5.97% | 2,101,533 -1,357,591 | -39% | -$3.39M |
|
|
8
Alerian MLP ETF
AMLP
$10.7B
| $4.53M | 5.14% | 459,744 +47,852 | +12% | +$471K |
|
9
SPDR S&P 500 ETF Trust
SPY
$658B
| $4.11M | 4.66% | 14,010 | – | – |
|
10
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.99M | 2.25% | 9,312 | – | – |
|
|
VIRX
11
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.92M | 2.18% | 2,645,826 +2,368,581 | +854% | +$1.72M |
|
|
EIGR
12
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $656K | 0.75% | 61,875 +12,590 | +26% | +$133K |
|
13
Kura Oncology
KURA
$686M
| $540K | 0.61% | 27,402 +8,128 | +42% | +$160K |
|
14
Mercado Libre
MELI
$125B
| $280K | 0.32% | 457 +22 | +5% | +$13.5K |
|
|
CTIC
15
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $279K | 0.32% | 324,452 +1,426 | +0.4% | +$1.23K |
|
|
GB
16
DELISTED
Global Blue Group Holding
GB
| $260K | 0.3% | 25,509 +56 | +0.2% | +$571 |
|
|
DRNA
17
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $244K | 0.28% | 15,487 -240 | -2% | -$3.78K |
|
18
FS KKR Capital
FSK
$5.11B
| $242K | 0.27% | 40,548 +90 | +0.2% | +$537 |
|
|
19
Visa
V
$683B
| $238K | 0.27% | +1,370 | New | +$238K |
|
|
20
Mastercard
MA
$538B
| $236K | 0.27% | +892 | New | +$236K |
|
21
Charter Communications
CHTR
$36.3B
| $234K | 0.27% | +591 | New | +$234K |
|
22
American Tower
AMT
$95.5B
| $232K | 0.26% | 1,136 +39 | +4% | +$7.97K |
|
23
Credit Acceptance
CACC
$5.78B
| $232K | 0.26% | 479 +19 | +4% | +$9.2K |
|
24
TransDigm Group
TDG
$78.8B
| $232K | 0.26% | 479 +21 | +5% | +$10.2K |
|
25
United Airlines
UAL
$34B
| $225K | 0.26% | +2,566 | New | +$225K |
|